Swedish researchers have discovered that patients with the neurodegenerative disorder had half the normal expected risk of developing tumors.
The Nutshell
Daily News Roundup
Most Recent
A vaccine that targets 90 percent of all cancers shows promise in early clinical trials.
Yet another study demonstrates that how pesticides might be related to the collapse of wild bee colonies.
Extra inches may mean a higher chance of getting ovarian cancer.
A deadly mushroom toxin shrinks pancreatic tumors in mice.
Researchers put the predictive power of whole genome sequencing to the test.
Bees exposed to neonicotinoids, a widely-used class of pesticide, navigate poorly and produce fewer queens, suggesting a role for neonicotinoids in colony collapse.
Once a promising cancer treatment, the failure of PARP inhibitors in the clinic may be due to flawed preclinical studies.
A new report outlines ways in which omics-based technologies can be shuttled more safely and effectively from the bench to the clinic.
Subjects
- cell & molecular biology
- clinical trials
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
